Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRT.

2% at 5 years) but did not reach statistical significance ( p = 0.052). 3.3 Prognostic Value of Impaired VCM Within the T2N0 glottic cancer cohort, MVA confirmed that patients with impaired VCM had significantly worse outcomes, with an adjusted hazard ratio (aHR) of 2.07 (95% CI, 1.17–3.67; p = 0.013) for OS, 2.74 (95% CI, 1.68–4.45; p < 0.001) for DFS, and 3.72 (95% CI, 1.79–7.71; p < 0.001) for LRF compared with those with normal VCM (Table 3 ).

also in 111,027 other papers